Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): Pathogenetic and diagnostic implications

Laboratory Investigation

Volumn 77, Issue 4, 1997, Pages 299-304

  Maury, Carl Peter J ^a   Sletten, Knut ^b   Totty, Nick ^c   Kangas, Hannele ^a   Liljeström, Mikko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OSLO   (Norway)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GELSOLIN;

AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FAMILIAL DISEASE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; GELSOLIN; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 0030661879     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. de la Chapelle A, Kere J, Sack GH, Tolvanen R, and Maury CPJ (1992a). Familial amyloidosis, Finnish type: G654-A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 13:898-901.
2. de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Blecker-Wagemakers L, Maury CPJ, and Kere J (1992b). Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 2:157-160.
3. Foyn-Bruun C, Rygg M, Nordstoga K, Sletten K, and Marhaug G (1994). Serum amyloid A protein in mink during endotoxin induced inflammation and amyloidogenesis. Scand J Immunol 40:337-344.
4. Kangas H, Paunio T, Kalkkinen N, Jalanko A, and Peltonen L (1996). In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum Mol Genet 5:1237-1243.
5. Kwiatkowski DJ, Stossel TP, Orkin SH, Mole JE, Colten HR, and Yin HL (1986). Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 323:455-458.
6. Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, P relli F, and Frangione B (1990). Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 172:1865-1867.
7. Maury CPJ (1991a). Gelsolin-related amyloidosis: Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest 87:1195-1199.
8. Maury CPJ (1991b). Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. Lab Invest 64:400-404.
9. Maury CPJ, Alli K, and Baumann M (1990a). Finnish hereditary amyloidosis: Amino acid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Lett 260:85-87.
10. Maury CPJ and Baumann M (1990). Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): Relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1096:84-86.
11. Maury CPJ, Kere J, Tolvanen R, and de la Chapelle A (1990b). Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett 276: 75-77.
12. Maury CPJ, Kere J, Tolvanen R, and de la Chapelle A (1992). Homozygosity for the Asn 187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13:903-903.
13. Maury CPJ and Nurmiaho-Lassila E-L (1992). Creation of amyloid fibrils from mutant Asn-187 gelsolin peptides. Biochem Biophys Res Commun 183:227-231.
14. Maury CPJ, Nurmiaho-Lassila E-L, and Rossi H (1994). Amyloid fibril formation in gelsolin-derived amyloidosis: Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab Invest 70:558-564.
15. Maury CPJ and Rossi H (1993). Demonstration of a circulating 65K gelsolin variant specific for familial amyloidosis, Finnish type. Biochem Biophys Res Commun 191:41-44.
16. McLaughlin PJ, Gooch JT, Mannherz H-G, and Weeds AG (1993). Structure of gelsolin segment 1-actin complex and the mechanism of filament severing. Nature 364:685-692.
17. Meretoja J (1969). Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms: A previously unrecognized heritable syndrome. Ann Clin Res 1:314-324.
18. Paunio T, Kangas H, Kalkkinen N, Haltia M, Palo J, and Peltonen L (1994). Toward understanding the pathogenetic mechanisms in gelsolin-related amyloidosis: In vitro expression reveals an abnormal gelsolin fragment. Hum Mol Genet 3:2223-2229.
19. Rosenfeld J, Capdevielle J, Guillemot JC, and Ferrara P (1992). In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional hgel electrophoresis. Anal Biochem 203:173-179.
20. Totty NF, Waterfield MD, and Hsuan J (1992). Accelerated high-sensitivity microsequencing of proteins and peptides using a miniature reaction cartridge. J Prot Sci 1:1215-1224.
21. Way M, Gooch J, Pope B, and Weeds AG (1989). Expression of human plasma gelsolin in Eschericia Coli and dissection of actin binding sites by segmental deletion mutagenesis. J Cell Biol 109:593-605.
22. Weeds AG, Gooch J, McLaughlin P, and Maury CPJ (1993). Variant gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity. FEBS Lett 335: 119-123.
23. Yamamoto H, Terabayashi M, Egawa T, Hayashi E, Nakamura JH, and Kishimoto S (1989). Affinity separation of human plasma gelsolin on Affi-Gel Blue. J Biochem 105:799-802.